RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vernadeth Alarcon to Hydroxylamines

Back to Details
This is a "connection" page, showing publications Vernadeth Alarcon has written about Hydroxylamines.
Vernadeth Alarcon
Connection Strength
0.233
Hydroxylamines
  1. Marikawa Y, Alarcon VB. An active metabolite of the anti-COVID-19 drug molnupiravir impairs mouse preimplantation embryos at clinically relevant concentrations. Reprod Toxicol. 2023 10; 121:108475.
    View in: PubMed
    Score: 0.233
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support